This inventor holds 1 USPTO granted patent. Top assignee: Sylus Pharmaceuticals Ltd.. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: The Innovations of Leslie Greenbaum
Introduction
Leslie Greenbaum is a notable inventor based in Surrey, GB. He has made significant contributions to the field of medical treatments, particularly in the area of ischaemia-reperfusion injury. His innovative work has led to the development of a patent that addresses critical health challenges.
Latest Patents
Greenbaum holds a patent for "Inositolphosphoglycan and ribose for treatment of ischaemia-reperfusion injury." This patent discloses compositions comprising inositolphosphoglycans (IPGs) and ribose, which are utilized in the prevention or treatment of ischaemic-reperfusion injury. The treatment enhances the energy-generating systems of cells by employing the mitochondrial oxidative restoration system. Additionally, the patent discusses the use of these compositions in preserving organs for transplantation.
Career Highlights
Greenbaum is associated with Sylus Pharmaceuticals Ltd., where he continues to work on innovative solutions in the pharmaceutical industry. His research and development efforts have positioned him as a key figure in advancing medical treatments.
Collaborations
Some of his notable coworkers include Thomas William Rademacher and Patricia McLean, who contribute to the collaborative efforts at Sylus Pharmaceuticals Ltd. Their combined expertise fosters an environment of innovation and progress.
Conclusion
Leslie Greenbaum's contributions to the field of medical treatments through his patent on ischaemia-reperfusion injury exemplify the impact of innovation in healthcare. His work continues to inspire advancements that can improve patient outcomes and organ preservation.